# Dorothee Oberdhan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/dorothee-oberdhan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 648 |
| Field | Genetic and Kidney Cyst Diseases |
| h-index | 14 |
| i10-index | 18 |
| Last Known Institution | Pharmaceutical Product Development (United States) |
| OpenAlex ID | https://openalex.org/A5036477114 |
| ORCID iD | 0000-0003-1034-9049 |
| Works | 67 |

## Researcher papers

Showing 12 of 14.

- [Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease](https://scholariq.org/papers/short-term-renal-hemodynamic-effects-of-tolvaptan-in-subjects-with-autosomal/)
- [Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function](https://scholariq.org/papers/short-term-effects-of-tolvaptan-in-individuals-with-autosomal-dominant/)
- [Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions](https://scholariq.org/papers/family-and-caregiver-spillover-effects-in-cost-utility-analyses-of-alzheimer-s/)
- [Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop](https://scholariq.org/papers/establishing-a-core-outcome-set-for-autosomal-dominant-polycystic-kidney-disease/)
- [Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument](https://scholariq.org/papers/development-of-the-autosomal-dominant-polycystic-kidney-disease-impact-scale-a/)
- [The societal economic burden of autosomal dominant polycystic kidney disease in the United States](https://scholariq.org/papers/the-societal-economic-burden-of-autosomal-dominant-polycystic-kidney-disease-in/)
- [OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD](https://scholariq.org/papers/overture-a-worldwide-prospective-observational-study-of-disease-characteristics/)
- [Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data](https://scholariq.org/papers/medical-resource-utilization-and-costs-associated-with-autosomal-dominant/)
- [The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations](https://scholariq.org/papers/the-nocturne-randomized-trial-comparing-2-tolvaptan-formulations/)
- [Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative Study](https://scholariq.org/papers/polycystic-kidney-disease-related-disease-burden-in-adolescents-with-autosomal/)
- [Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry](https://scholariq.org/papers/pain-and-health-related-quality-of-life-in-autosomal-dominant-polycystic-kidney/)
- [Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study](https://scholariq.org/papers/disconnect-in-assessments-of-autosomal-dominant-polycystic-kidney-disease-burden/)

## Researcher topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Attention Deficit Hyperactivity Disorder](https://scholariq.org/topics/attention-deficit-hyperactivity-disorder/)
- [Biological Research and Disease Studies](https://scholariq.org/topics/biological-research-and-disease-studies/)

## Researcher university

- [Pharmaceutical Product Development (United States)](https://scholariq.org/institutions/pharmaceutical-product-development-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.